Delivery Order SPE2DB25D3201-SPE2DB25FNNRT

Award Date 11/5/24
Potential Completion Date 11/6/24
Potential Value $7.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,530.88 firm fixed-price delivery order is for the supply of CORLANOR 7.5 MG TABLET 60S, a cardiovascular medication. The contract has a completion date of March 21, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,936.06 Firm Fixed Price Delivery Order covers the supply of CORLANOR 5 MG TABLET 60S, a medication used for cardiovascular health. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,165.26 firm fixed-price delivery order is for the supply of CORLANOR 7.5 MG TABLET 60S, a medication used to treat heart failure. The contract has an ultimate completion date of January 6, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,232.26 Firm Fixed Price Delivery Order contract covers the supply of the medication CORLANOR 5 MG TABLET 60S, with a period of performance through September 4, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,659.47 firm fixed-price delivery order is for the supply of CORLANOR 5 MG TABLET 60S, a pharmaceutical product. The contract has a completion date of March 14, 2025 and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,280.93 firm-fixed-price delivery order is for the supply of CORLANOR 5 MG TABLET 60S, a medication used for the treatment of cardiovascular conditions. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,898.14 firm fixed-price delivery order contract is for the supply of CORLANOR 5 MG TABLET 60S, a pharmaceutical product, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract has an ultimate completion date of January 9, 2024 and does not...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,487.24 firm fixed-price delivery order is for the supply of CORLANOR 5 MG TABLET 60S, a cardiovascular medication. The contract has a completion date of February 11, 2025 and was awarded on February 10, 2025. There was no set-aside designation for this award. AmerisourceBergen holds a $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,375.20 firm fixed-price delivery order is for the provision of 4566632400 CORLANOR 5 MG TABLET 60S, a pharmaceutical product. The award is not associated with a set-aside designation. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,693.10 firm fixed-price delivery order is for the supply of CORLANOR 5 MG TABLET 60S, a cardiovascular medication. The contract has an ultimate completion date of December 18, 2023 and was awarded on December 15, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
  • SPE2DB25D3201
    Indefinite Delivery Contract
  • SPE2DB25D3201-SPE2DB25FNNRT
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,294.44 firm-fixed-price delivery order is for the supply of CORLANOR 5 MG TABLET 60S, a medication used to treat certain heart conditions.

The award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

In addition to the DLA contract, AmerisourceBergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/4/25, 10:43 AM